Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 146961 | Bar Harbor Bankshares (42K.F) | XFRA | US | 2023-12-31 | 1 week ago | USD | 0.00 | 42.46 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 146962 | CRH PLC (XCRA.SW) | XSWX | IE | 2022-12-31 | 8 months ago | USD | 0.00 | 42.47 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 146963 | CRH PLC (CRGI.TU) | TRQX | IE | 2022-12-31 | 8 months ago | USD | 0.00 | 42.47 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 146964 | Ligand Pharmaceuticals Inc (LGDN.MU) | XMUN | US | 2023-12-31 | 1 day ago | USD | 0.00 | 42.49 | 0.00% | 8.61 | 0.00% | NCAV (Net-Net) | 8.61 | 0.00% |
| 146965 | Guaranty Bancshares Inc (GNTY) | XNYS | US | 2023-12-31 | 1 day ago | USD | 30.28 | 42.49 | 140.33% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 146966 | Ligand Pharmaceuticals Inc (LGND) | XNAS | US | 2023-12-31 | 1 day ago | USD | 73.90 | 42.49 | 57.50% | 8.61 | 11.65% | NCAV (Net-Net) | 8.61 | 11.65% |
| 146967 | Enpro Inc (NPO) | XNYS | US | 2023-12-31 | 1 day ago | USD | 152.00 | 42.49 | 27.95% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 146968 | Ligand Pharmaceuticals Inc (LGDN.SW) | XSWX | US | 2023-12-31 | 1 month ago | USD | 0.00 | 42.49 | 0.00% | 8.61 | 0.00% | NCAV (Net-Net) | 8.61 | 0.00% |
| 146969 | Ligand Pharmaceuticals Inc (LGDN.SG) | XSTU | US | 2023-12-31 | 1 day ago | USD | 0.00 | 42.49 | 0.00% | 8.61 | 0.00% | NCAV (Net-Net) | 8.61 | 0.00% |
| 146970 | Ligand Pharmaceuticals Inc (LGDN.TG) | XGAT | US | 2023-12-31 | 2 days ago | USD | 0.00 | 42.49 | 0.00% | 8.61 | 0.00% | NCAV (Net-Net) | 8.61 | 0.00% |